Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
More than a century after Srinivasa Ramanujan scribbled his astonishing formulas for π in notebooks in India and England, ...
In 1914, Indian mathematician Srinivasa Ramanujan published a short paper detailing several unusual formulas for calculating ...